Sign In
Buy NVO
$47.64
+0.230 (+0.485%)
At Close: Jun 25, 2026
Tariffs on generic drugs will cause companies to stop making them: Former FDA Commissioner Gottlieb
10:29am, Tuesday, 15'th Apr 2025
Dr. Scott Gottlieb, former FDA Commissioner, joins 'Squawk Box' to discuss current pharmaceutical imports under investigation, moving production for branded and generic drugs elsewhere, and much more.
The Tariff Game Just Changed: 7 Blue-Chip Bargains To Buy Now
09:09am, Tuesday, 15'th Apr 2025
Unprecedented Opportunities: Recent market panic has created deep discounts among world-class blue-chip companies trading at 52-week lows, offering up to 100% potential returns and secure yields appro
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
04:00pm, Monday, 14'th Apr 2025
The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices, home care and digital health.
Trump Says Pharmaceutical Tariffs Coming in Near Future
02:03pm, Monday, 14'th Apr 2025
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with repo
Trump says US pharma tariffs coming in not-too-distant future
12:26pm, Monday, 14'th Apr 2025
U.S. President Donald Trump said on Monday that he expects to impose tariffs on imported pharmaceuticals in the not-too-distant future.
Novo Nordisk warns consumers about counterfeit versions of Ozempic in US
11:20am, Monday, 14'th Apr 2025
Novo Nordisk said on Monday it has become aware of several hundred units of counterfeit versions of its diabetes drug Ozempic being distributed outside its authorized supply chain in the United States
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
11:12am, Monday, 14'th Apr 2025
Bad news for Pfizer (PFE 1.07%) turned into good news for Eli Lilly (LLY 2.42%), Novo Nordisk (NVO 2.23%), and Viking Therapeutics (VKTX 8.48%) Monday morning, each of which is rising on Pfizer's late
We see about 50% upside on Novo Nordisk, but there are risks, says strategist
12:31pm, Friday, 11'th Apr 2025
Michael Field, chief EMEA equity strategist at Morningstar, discusses European stocks amid tariff uncertainty.
Here's Why Novo Nordisk (NVO) is a Strong Value Stock
10:46am, Friday, 11'th Apr 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
10:30am, Friday, 11'th Apr 2025
President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told
This Pharma Giant Will Invest $23 Billion in the U.S. It's a Sign Trump's Tariffs Are Working.
08:28am, Friday, 11'th Apr 2025
The Company spend billions to produce 100% of its key medicines for Americans in the U.S.
Pharma Stocks Rebound as Trump Announces a 90-Day Pause on Tariffs
09:55am, Thursday, 10'th Apr 2025
The news of a likely import tariff hurt the share price of pharma giants like Novo Nordisk (NVO), Eli Lilly (LLY) and AstraZeneca (AZN), but Trump's announcement of a pause on reciprocal tariffs offse
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
04:45am, Thursday, 10'th Apr 2025
European stocks soared on Thursday after U.S. President Donald Trump's jarring about-turn on most tariffs. Tensions between Washington and Beijing remain high, however, with Trump ratcheting up duties
BMO's Siegerman talks the impact of tariffs on pharmaceutical stocks
06:32pm, Wednesday, 09'th Apr 2025
Evan Seigerman, BMO, joins 'Fast Money' to talk the impact of tariffs on pharma space.
Trump's Tariffs Circle Pharma Industry: Who It Affects And How It May Play Out
03:59pm, Wednesday, 09'th Apr 2025
The Trump administration's proposed tariffs on pharmaceuticals have caused significant market turmoil today, with major Pharma stocks plummeting globally. Despite pledges to increase U.S. manufacturin
